Evidence map›Paper›PMID 26236074›Full record

ArticlePublic health reviews

Evaluating Changes in the Prevalence of the Autism Spectrum Disorders (ASDs).

Catherine E Rice, Michael Rosanoff, Geraldine Dawson, Maureen S Durkin, Lisa A Croen, Alison Singer, Marshalyn Yeargin-Allsopp

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Public health reviews. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Prenatal exposure to extreme heat and autism in children.The Science of the total environment · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Experiences of siblings of individuals with autism spectrum disorders.International journal of developmental disabilities · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Catherine E RiceNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, USA.
Michael RosanoffAutism Speaks, USA.
Geraldine DawsonAutism Speaks, USA ; University of North Carolina at Chapel Hill, USA.
Maureen S DurkinUniversity of Wisconsin-Madison, USA.
Lisa A CroenKaiser Permanente® Autism Research Program, USA.
Alison SingerAutism Science Foundation, USA.
Marshalyn Yeargin-AllsoppNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Autism spectrum disorders (ASDs) are estimated to occur among about one percent of children in the United States. This estimate is in line with estimates from other industrialized countries. However, the identified prevalence of ASDs has increased significantly in a short time period based on data from multiple studies including the U.S. Centers for Disease Control and Prevention's (CDC) Autism and Developmental Disabilities Monitoring (ADDM) Network. Whether increases in ASD prevalence are partly attributable to a true increase in the risk of developing ASD or solely to changes in community awareness and identification patterns is not known. It is clear that more children are identified with an ASD now than in the past and the impact on individuals, families, and communities is significant. However, disentangling the many potential reasons for ASD prevalence increases has been challenging. Understanding the relative contribution of multiple factors such as variation in study methods, changes in diagnostic and community identification, and potential changes in risk factors is an important priority for the ADDM Network and for CDC. This article summarizes the discussion from a workshop that was co-sponsored by CDC and Autism Speaks as a forum for sharing knowledge and opinions of a diverse range of stakeholders about changes in ASD prevalence. Panelists discussed recommendations for building on existing infrastructure and developing new initiatives to better understand ASD trends. The information, research, and opinions shared during this workshop add to the knowledge base about ASD prevalence in an effort to stimulate further work to understand the multiple reasons behind increasing ASD prevalence.

Indexed as

ASDAutismautism spectrum disordersoccurrenceprevalence

Identifiers

PMID26236074
PMCPMC4520794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.